Standard induction therapy with lenalidomide, bortezomib, and dexamethasone did not overcome inferior outcomes in patients ...
Study finds low peripheral blood lymphocyte count at diagnosis predicts worse overall survival in multiple myeloma patients.
Peripheral blood absolute lymphocyte count at diagnosis is an effective biomarker that can be used to risk-stratify patients with multiple myeloma, according to retrospective study results.Continued ...
A mixed methods evaluation of the Canopy Cancer Collective’s implementation of network-wide screening initiative in 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback